What Would It Take For Rising Medical Costs To Break UnitedHealth Stock?

UnitedHealth Group (UNH) stock trades at 25.6 times its earnings over the last twelve months. That valuation represents a premium against 22.9 for the S&P 500, suggesting investors are betting on a profit recovery. On October 13, 2026, the company raised its guidance for the full year. During the earnings call that day, executives warned that cost trends for commercial benefits are exceeding initial expectations of 11%. They cited high-cost specialty drugs and the No Surprises Act. So how much profit would UnitedHealth lose if its medical costs rose by an extra 1% of its health-plan revenue?

UnitedHealth’s Bill For Each Point Of Higher Costs

Each such point would cost UnitedHealth about $3.45 billion across all of its health plans, extending beyond the commercial plans where executives flagged the higher cost trend. UnitedHealthcare operates the company’s health plans and brought in $345 billion of revenue during FY2025. That makes one percentage point of revenue equal to the $3.45 billion figure. Based on the company’s raised EPS outlook of at least $19.50 per share, we estimate 2026 net earnings will be approximately $17.7 billion. A one-point overrun would dent that profit rather than erase it, while a bill of just over five such points would equal that whole year’s profit.

A shift of that magnitude is not far-fetched. Executives put the consolidated medical care ratio, a measure of what it pays out for care, at 88.4% for fiscal Q3 2026, against 89.9% a year earlier. The ratio swung by more than a point within a year, although this time the move worked in UnitedHealth’s favor. Executives also singled out disputes under the No Surprises Act, noting that arbitration awards can approach 6% of total medical spend in some regions.

How Much Cash UnitedHealth Has Against A Cost Overrun

UnitedHealth generated $23.6 billion of free cash flow, the cash left after capital spending, over the twelve months to June 30, 2026. That cash pile easily exceeds a one-point bill. Dividends consume a large portion of that cash, since executives expect to pay more than $8 billion in 2026. The company pays its interest out of operating profit with room to spare, as operating income covered interest expense 5.6 times over those twelve months.

When pricing its plans for 2027, executives took the view that these cost trends would continue into 2027. Parts of the business also sit outside the health plans. The Optum Rx pharmacy unit brought in $155 billion of revenue in FY2025. That revenue was up 16.1% from a year earlier. During the October call, executives noted that for the first time, more than half of Optum Rx membership comes from outside UnitedHealth’s own plans.

What UnitedHealth Holders Should Watch Next

The Medicare annual enrollment period for UnitedHealth began in the week of the October 13 call. Executives plan to share more details regarding 2027 before the end of the year. The shares also carry a history of sharp swings. Between February and June 2025, UnitedHealth stock fell 46% from its peak to its low, against 19% for the S&P 500. Investors should watch the medical care ratio in the next quarterly report, expected on or around January 25, 2027.

Does This Mean You Should Act On UNH?

Our purpose is to inform you with unique data so you make the right investment decisions. That said, betting on a single stock is always risky, no matter which direction you choose.

There is a smarter approach. Since its inception, the Trefis High Quality (HQ) Portfolio has returned 105%, beating the benchmark that combines the three major indices – the S&P 500, S&P Mid-cap, and Russell 2000. And it did so without taking the concentrated risk that comes with do-it-yourself stock picking. If that is how you want to invest, the HQ Portfolio is the place to start.